Relationship between the apolipoprotein E and angiotensin-converting enzyme genotypes and LDL particle size in Japanese subjects.

[1]  R. Darioli,et al.  Apolipoprotein E polymorphism and the distribution profile of very low density lipoproteins; an influence of the E4 allele on large (Sf > 60) particles. , 1998, Atherosclerosis.

[2]  T. Arinami,et al.  Methylenetetrahydrofolate reductase and apolipoprotein E polymorphisms are independent risk factors for coronary heart disease in Japanese: a case-control study. , 1998, Atherosclerosis.

[3]  R. Krauss,et al.  Influence of apoE content on receptor binding of large, bouyant LDL in subjects with different LDL subclass phenotypes. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[4]  K. Okumura,et al.  Low density lipoprotein particle size is associated with glycosylated hemoglobin levels regardless of plasma lipid levels. , 1998, Internal medicine.

[5]  J. Staessen,et al.  The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular‐renal risk , 1997, Journal of hypertension.

[6]  N. Yoshiike,et al.  Association of apolipoprotein genetic polymorphisms with plasma cholesterol in a Japanese rural population. The Shibata Study. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[7]  R. Mayeux,et al.  Association of apo E polymorphism with plasma lipid levels in a multiethnic elderly population. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[8]  R. Krauss,et al.  Associations of age, adiposity, menopause, and alcohol intake with low-density lipoprotein subclasses. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[9]  B. Howard,et al.  Apolipoprotein E polymorphism and LDL size in a biethnic population. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[10]  T. Ogihara,et al.  Polymorphism of the apolipoprotein E and angiotensin-converting enzyme genes in Japanese subjects with silent myocardial ischemia. , 1996, Hypertension.

[11]  M. Margaglione,et al.  Deletion polymorphism in the angiotensin-converting enzyme gene in patients with a history of ischemic stroke. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[12]  J. Ordovás,et al.  Effects of diet and exercise on qualitative and quantitative measures of LDL and its susceptibility to oxidation. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[13]  G. MacGregor,et al.  Genetic risk for renal artery stenosis: association with deletion polymorphism in angiotensin 1-converting enzyme gene. , 1996, Kidney international.

[14]  G. MacGregor,et al.  Genetic risk for renal artery stenosis: association with deletion polymorphism in angiotensin I-converting enzyme gene , 1995 .

[15]  W. Shelledy,et al.  Effect of diabetes on lipoprotein size. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[16]  M. Quiñones,et al.  Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. , 1995, Circulation.

[17]  Meyers Br,et al.  Transesophageal echocardiography in the diagnosis of traumatic rupture of the aorta. , 1995 .

[18]  D. Wilcken,et al.  Polymorphisms of the apolipoprotein E gene and severity of coronary artery disease defined by angiography. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[19]  H. Markus,et al.  Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma. , 1995, Stroke.

[20]  T. Katsuya,et al.  Relations between deletion polymorphism of the angiotensin-converting enzyme gene and insulin resistance, glucose intolerance, hyperinsulinemia, and dyslipidemia. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[21]  R Kreutz,et al.  A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. , 1995, The New England journal of medicine.

[22]  R. Krauss,et al.  Persistence of low HDL-C levels after weight reduction in older men with small LDL particles. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[23]  H. Gylling,et al.  Cholesterol absorption and metabolism and LDL kinetics in healthy men with different apoprotein E phenotypes and apoprotein B Xba I and LDL receptor Pvu II genotypes. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[24]  B. Howard,et al.  Greater Effect of Diabetes on LDL size in Women Than in Men , 1994, Diabetes Care.

[25]  L. Tiret,et al.  Plasma Level and Gene Polymorphism of Angiotensin‐Converting Enzyme in Relation to Myocardial Infarction , 1994, Circulation.

[26]  R. Hegele,et al.  Apolipoprotein E in Hyperlipidemia , 1994, Annals of Internal Medicine.

[27]  R. Krauss,et al.  LDL Subclass Phenotypes and the Insulin Resistance Syndrome in Women , 1993, Circulation.

[28]  R. Krauss,et al.  Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. , 1993, The Journal of clinical investigation.

[29]  O. Costerousse,et al.  Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. , 1993, The Biochemical journal.

[30]  P. Wilson,et al.  Change in LDL particle size is associated with change in plasma triglyceride concentration. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[31]  Philippe Amouyel,et al.  Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction , 1992, Nature.

[32]  R. Krauss,et al.  Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. , 1992, Atherosclerosis.

[33]  R. Krauss,et al.  Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm of chromosome 19. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[34]  C. Packard,et al.  Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects. , 1991, The Journal of clinical investigation.

[35]  J. Hendriks,et al.  Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[36]  P Corvol,et al.  An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. , 1990, The Journal of clinical investigation.

[37]  G. Bondjers,et al.  Effect of proteoglycans on lipoprotein-cell interactions: possible contribution to atherogenesis , 1990 .

[38]  M. King,et al.  Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. , 1990, Circulation.

[39]  G. Yoshino,et al.  Abnormal Lipoprotein Composition in Normolipidemic Diabetic Patients , 1990, Diabetes Care.

[40]  P. Gambert,et al.  Human low density lipoprotein subfractions separated by gradient gel electrophoresis: composition, distribution, and alterations induced by cholesteryl ester transfer protein. , 1990, Journal of lipid research.

[41]  D. T. Vernier,et al.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.

[42]  W C Willett,et al.  Low-density lipoprotein subclass patterns and risk of myocardial infarction. , 1988, JAMA.

[43]  P. Wilson,et al.  Effect of Gender, Age, and Lipid Status on Low Density Lipoprotein Su bf raction Distribution: Results from the Framingham Offspring Study , 1987, Arteriosclerosis.

[44]  C. Ehnholm,et al.  Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. , 1987, The Journal of clinical investigation.

[45]  P. Wilson,et al.  Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. , 1986, JAMA.

[46]  R. Gregg,et al.  Abnormal in vivo metabolism of apolipoprotein E4 in humans. , 1986, The Journal of clinical investigation.

[47]  F. Kahl,et al.  Studies of low density lipoprotein molecular weight in human beings with coronary artery disease. , 1985, Journal of lipid research.

[48]  R. Krauss,et al.  Heterogeneity of serum low density lipoproteins in normal human subjects. , 1981, Journal of lipid research.

[49]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[50]  F. Baralle,et al.  Polymorphism of the apolipoprotein E gene and early carotid atherosclerosis defined by ultrasonography in asymptomatic adults. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[51]  C. Sing,et al.  Apolipoprotein E polymorphism and atherosclerosis. , 1988, Arteriosclerosis.

[52]  R. Krauss,et al.  Identification of multiple subclasses of plasma low density lipoproteins in normal humans. , 1982, Journal of lipid research.

[53]  A. Bøyum,et al.  Isolation of mononuclear cells and granulocytes from human blood. , 1968 .